Subscribe
206 – End of Year Rewind – Dr. Danielle Ofri: Is our biggest strength our greatest weakness?

Docs Outside The Box

206 – End of Year Rewind – Dr. Danielle Ofri: Is our biggest strength our greatest weakness?

Our 4th most downloaded episode this year was Episode 153 - Is our biggest strength our greatest weakness? It’s well known that doctors put patients first even though it may…
December 31, 2020
ADVERTISEMENT
EHRGo-THE FUTURE OF HEALTHCARE EDUCATION

206 – End of Year Rewind – Dr. Danielle Ofri: Is our biggest strength our greatest weakness?

Our 4th most downloaded episode this year was Episode 153 – Is our biggest strength our greatest weakness?

It’s well known that doctors put patients first even though it may have negative social effects on doctors. Whether we call it professionalism or an edict, this way of life has allowed us to be viewed as unbiased advocates for our patients.

 

Dr. Danielle Ofri joins me on this episode to discuss an Op-Ed she wrote in the NY Times last year discussing if our professionalism is being taken advantage of by hospitals.  Dr. Danielle Ofri  is an internist at Bellevue Hospital and NYU School of Medicine. She writes regularly for the New York Times, Slate Magazine and other publications about medicine and the doctor-patient relationship. Dr. Ofri is the author of five books, including, most recently, “What Patients Say; What Doctors Hear.” Her TED talks include Deconstructing Perfection and Fear: A Necessary Emotion.

 

Transcription:

(coming soon)

 

This episode is sponsored by Provider Solutions & Development. Experts in holistic career coaching – check them out at www.psdrecruit.org/docsoutsidethebox

 

 

ADVERTISEMENT
EHRGo-THE FUTURE OF HEALTHCARE EDUCATION

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Best Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Hera Diagnostics is eradicating cervical cancer in developing communities Teo Tijerina is the CEO of Hera Medical Devices, a cancer diagnostics startup currently focusing on bringing a cervical cancer screening tool to market.